Emergent BioSolutions Inc. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Emergent BioSolutions Inc. for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Gift | G | 0.00 | 1,800 | 0 | 37,465 | 39.3 K to 37.5 K (-4.58 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 31.05 | 1,624 | 50,425 | 39,265 | 40.9 K to 39.3 K (-3.97 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 30.98 | 1,076 | 33,334 | 40,889 | 42 K to 40.9 K (-2.56 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 31.05 | 3,007 | 93,367 | 82,095 | 85.1 K to 82.1 K (-3.53 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 30.98 | 1,908 | 59,110 | 85,102 | 87 K to 85.1 K (-2.19 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 31.05 | 10,738 | 333,415 | 204,134 | 214.9 K to 204.1 K (-5.00 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.98 | 8,226 | 254,841 | 214,872 | 223.1 K to 214.9 K (-3.69 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 20,554 | 0 | 62,064 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 13,236 | 0 | 82,618 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 31.05 | 6,089 | 189,063 | 1,680,216 | 1.7 M to 1.7 M (-0.36 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 20,554 | 0 | 1,686,305 | 1.7 M to 1.7 M (+1.23 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 30.98 | 3,621 | 112,179 | 1,665,751 | 1.7 M to 1.7 M (-0.22 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 13,236 | 0 | 1,669,372 | 1.7 M to 1.7 M (+0.80 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | J | 25.47 | 905 | 23,050 | 10,305 | |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 31.27 | 2,576 | 80,558 | 16,009 | 18.6 K to 16 K (-13.86 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 577 | 0 | 18,585 | 18 K to 18.6 K (+3.20 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 604 | 0 | 18,008 | 17.4 K to 18 K (+3.47 %) |
| Mar 10 2017 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Buy | J | 0.00 | 453 | 0 | 17,404 | 17 K to 17.4 K (+2.67 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 30.63 | 58,747 | 1,799,421 | 58,747 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,722 | 0 | 95,854 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 29,382 | 0 | 105,576 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 30.63 | 2,659 | 81,445 | 1,656,136 | 1.7 M to 1.7 M (-0.16 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,722 | 0 | 1,658,795 | 1.6 M to 1.7 M (+0.59 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | A | 30.63 | 32,638 | 999,702 | 32,638 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 30.86 | 2,847 | 87,858 | 32,397 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 26.45 | 2,121 | 56,100 | 24,132 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Option Exercise | J | 25.62 | 1,672 | 42,837 | 19,026 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Payment of Exercise | F | 30.63 | 1,799 | 55,103 | 87,010 | 88.8 K to 87 K (-2.03 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Grant | A | 0.00 | 8,162 | 0 | 88,809 | 80.6 K to 88.8 K (+10.12 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Grant | A | 0.00 | 8,161 | 0 | 80,647 | 72.5 K to 80.6 K (+11.26 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,425 | 0 | 72,486 | 71.1 K to 72.5 K (+2.01 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,061 | 0 | 71,061 | 70 K to 71.1 K (+1.52 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corproate Serv ... | Buy | J | 0.00 | 1,672 | 0 | 70,000 | 68.3 K to 70 K (+2.45 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 30.63 | 17,134 | 524,814 | 17,134 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 30.63 | 938 | 28,731 | 41,965 | 42.9 K to 42 K (-2.19 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 4,285 | 0 | 42,903 | 38.6 K to 42.9 K (+11.10 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 4,285 | 0 | 38,618 | 34.3 K to 38.6 K (+12.48 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 30.63 | 78,329 | 2,399,217 | 78,329 | |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 6,184 | 189,416 | 223,098 | 229.3 K to 223.1 K (-2.70 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 19,589 | 0 | 229,282 | 209.7 K to 229.3 K (+9.34 %) |
| Mar 02 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 19,588 | 0 | 209,693 | 190.1 K to 209.7 K (+10.30 %) |
| Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 14.51 | 3,662 | 53,136 | 0 | |
| Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 984 | 30,140 | 190,105 | 191.1 K to 190.1 K (-0.51 %) |
| Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 30.63 | 1,735 | 53,143 | 191,089 | 192.8 K to 191.1 K (-0.90 %) |
| Mar 01 2017 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 30.63 | 3,662 | 112,167 | 192,824 | 189.2 K to 192.8 K (+1.94 %) |